Xuchao Lyu

Dr. Xuchao Lyu

Altos Labs, San Francisco, California, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Nature
Verified
Journal Article
Closed access
PDF file
VLVeronica L. Li
Veronica L. Li
YHYang He
Yang He
Kevin ContrepoisKevin Contrepois
Kevin Contrepois
HLHailan Liu
Hailan Liu
JKJoon T. Kim
Joon T. Kim
JLJonathan Z. Long
Jonathan Z. Long

3 May 2023 in Cell Metabolism
Verified
Journal Article
Closed access
WWWei Wei
Wei Wei
NRNicholas M. Riley
Nicholas M. Riley
XLXuchao Lyu
Xuchao Lyu
XSXiaotao Shen
Xiaotao Shen
JGJing Guo
Jing Guo
JLJonathan Z. Long
Jonathan Z. Long

20 December 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SWSongnan Wang
Songnan Wang
VBVolker Böhnert
Volker Böhnert
AJAlby J. Joseph
Alby J. Joseph
VSValentino Sudaryo
Valentino Sudaryo
GSGemini Skariah
Gemini Skariah
LLLingyin Li
Lingyin Li
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) expression correlates with poor prognosis in many cancers, and we previously discovered that ENPP1 is the dominant hydrolase of extracellular cGAMP: a cancer-cell-produced immunotransmitter that activates the anticancer stimulator of interferon genes (STING) pathway. However, ENPP1 has other catalytic activities and the molecular and cellular mechanisms contributing to its tumorigenic effects remain unclear. Here, using single-cell RNA-seq, we show that ENPP1 in both cancer and normal tissues drives primary breast tumor growth and metastasis by dampening extracellular 2′3′-cyclic-GMP-AMP (cGAMP)–STING-mediated antitumoral immunity. ENPP1 loss-of-function in both cancer cells and normal tissues slowed primary tumor growth and abolished metastasis. Selectively abolishing the cGAMP hydrolysis activity of ENPP1 phenocopied ENPP1 knockout in a STING-dependent manner, demonstrating that restoration of paracrine cGAMP–STING signaling is the dominant anti-cancer mechanism of ENPP1 inhibition. Finally, ENPP1 expression in breast tumors deterministically predicated whether patients would remain free of distant metastasis after pembrolizumab (anti-PD-1) treatment followed by surgery. Altogether, ENPP1 blockade represents a strategy to exploit cancer-produced extracellular cGAMP for controlled local activation of STING and is therefore a promising therapeutic approach against breast cancer.

18 March 2024 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
SXShuke Xiao
Shuke Xiao
VLVeronica L. Li
Veronica L. Li
XLXuchao Lyu
Xuchao Lyu
XCXudong Chen
Xudong Chen
WWWei Wei
Wei Wei
JLJonathan Z. Long
Jonathan Z. Long

7 August 2024 in Nature
Verified
Journal Article
Open access
PDF file
WWWei Wei
Wei Wei
XLXuchao Lyu
Xuchao Lyu
AMAndrew L. Markhard
Andrew L. Markhard
SFSipei Fu
Sipei Fu
RMRachel E. Mardjuki
Rachel E. Mardjuki
JLJonathan Z. Long
Jonathan Z. Long
Taurine is a conditionally essential micronutrient and one of the most abundant amino acids in humans1–3. In endogenous taurine metabolism, dedicated enzymes are involved in the biosynthesis of taurine from cysteine and in the downstream metabolism of secondary taurine metabolites4,5. One taurine metabolite is N-acetyltaurine6. Levels of N-acetyltaurine are dynamically regulated by stimuli that alter taurine or acetate flux, including endurance exercise7, dietary taurine supplementation8 and alcohol consumption6,9. So far, the identities of the enzymes involved in N-acetyltaurine metabolism, and the potential functions of N-acetyltaurine itself, have remained unknown. Here we show that the body mass index associated orphan enzyme phosphotriesterase-related (PTER)10 is a physiological N-acetyltaurine hydrolase. In vitro, PTER catalyses the hydrolysis of N-acetyltaurine to taurine and acetate. In mice, PTER is expressed in the kidney, liver and brainstem. Genetic ablation of Pter in mice results in complete loss of tissue N-acetyltaurine hydrolysis activity and a systemic increase in N-acetyltaurine levels. After stimuli that increase taurine levels, Pter knockout mice exhibit reduced food intake, resistance to diet-induced obesity and improved glucose homeostasis. Administration of N-acetyltaurine to obese wild-type mice also reduces food intake and body weight in a GFRAL-dependent manner. These data place PTER into a central enzymatic node of secondary taurine metabolism and uncover a role for PTER and N-acetyltaurine in body weight control and energy balance.

12 November 2024 in Cell
Verified
Journal Article
Open access
MMMaria Dolores Moya-Garzon
Maria Dolores Moya-Garzon
MWMengjie Wang
Mengjie Wang
VLVeronica L. Li
Veronica L. Li
XLXuchao Lyu
Xuchao Lyu
WWWei Wei
Wei Wei
JLJonathan Z. Long
Jonathan Z. Long
β-Hydroxybutyrate (BHB) is an abundant ketone body. To date, all known pathways of BHB metabolism involve the interconversion of BHB and primary energy intermediates. Here, we identify a previously undescribed BHB secondary metabolic pathway via CNDP2-dependent enzymatic conjugation of BHB and free amino acids. This BHB shunt pathway generates a family of anti-obesity ketone metabolites, the BHB-amino acids. Genetic ablation of CNDP2 in mice eliminates tissue amino acid BHB-ylation activity and reduces BHB-amino acid levels. The most abundant BHB-amino acid, BHB-Phe, is a ketosis-inducible congener of Lac-Phe that activates hypothalamic and brainstem neurons and suppresses feeding. Conversely, CNDP2-KO mice exhibit increased food intake and body weight following exogenous ketone ester supplementation or a ketogenic diet. CNDP2-dependent amino acid BHB-ylation and BHB-amino acid metabolites are also conserved in humans. Therefore, enzymatic amino acid BHB-ylation defines a ketone shunt pathway and bioactive ketone metabolites linked to energy balance.